MyAverix Finance
US · Healthcare
Regenerative Medical Technology Group Inc. (RMTG)
Biotechnology
Regenerative Medical Technology Group Inc. (RMTG) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for RMTG
Regenerative Medical Technology Group Inc. (RMTG) — FAQ
What is RMTG's P/E ratio?
The price-to-earnings (P/E) ratio for Regenerative Medical Technology Group Inc. (RMTG) is 25.00 (data as of 2026-05-23).
Does Regenerative Medical Technology Group Inc. pay a dividend?
Dividend yield is not available in the current snapshot for Regenerative Medical Technology Group Inc. (RMTG). Check the MyAverix Finance app for the latest dividend data.
What sector is Regenerative Medical Technology Group Inc. in?
Regenerative Medical Technology Group Inc. (RMTG) is classified in the Healthcare sector (Biotechnology industry).
What exchange is RMTG listed on?
RMTG is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.